Royal Brompton & Harefield NHS Foundation Trust Chooses CSC for Transformational IT Systems
News Release -- December 10, 2014
CSC (NYSE: CSC), a global leader in next-generation IT services and solutions, today announced that Royal Brompton & Harefield NHS Foundation Trust has chosen two of its innovative healthcare software solutions. The Trust, the largest specialist heart and lung centre in the UK, will employ the Lorenzo electronic patient record (EPR) system, and the MedChart electronic medication management system.
Joanna Smith, CIO at Royal Brompton & Harefield NHS Foundation Trust, said, “We set out to choose the technology for our transformation programme on a ‘best-of-breed’ basis. Through a rigorous competitive process, we concluded that CSC’s Lorenzo and MedChart will allow us to accelerate our transformation plan, and enable us to provide better care for patients.”
Lorenzo is a fully-featured next-generation EPR, which has been designed specifically to meet the needs of NHS hospital trusts. It is already live in 12 NHS trusts, with a further five deploying over the next year. Royal Brompton & Harefield NHS Foundation Trust is the second to take Lorenzo outside of the terms of a central agreement between CSC and the UK Department of Health.
MedChart, is already used by leading hospitals in Australia, New Zealand and the UK. It is a web-based solution, which includes electronic prescribing, pharmacy review, drug administration and clinical decision support. Designed by clinicians, it streamlines the medication prescribing, pharmacy review and administration processes to reduce risk, harm, confusion, error and inefficiency and improve coordination between clinical teams.
Philippe Houssiau, CSC vice president responsible for UK Healthcare, said, “We are delighted that Royal Brompton & Harefield NHS Foundation Trust has chosen both Medchart and Lorenzo. Lorenzo will bring real clinical benefits, including easier access and sharing of information, improved clinical risk management and quicker referral triage. Independent studies have shown that MedChart is associated in a significant reduction in medical errors. We look forward to building on our existing relationship with the Trust as it continues to transform care delivery.”
About Royal Brompton & Harefield NHS Foundation Trust
Royal Brompton & Harefield NHS Foundation Trust is the largest specialist heart and lung centre in the UK and among the largest in Europe. It carries out some of the most complicated surgery and offers some of the most sophisticated treatment that is available anywhere in the world, treating patients from all over the UK and around the globe. The Trust has a worldwide reputation for heart and lung research and i-Your data has been truncated.
Computer Sciences Corporation (CSC) is a global leader of next generation information technology (IT) services and solutions. The Company's mission is to enable superior returns on our client's technology investments through best-in-class industry solutions, domain expertise and global scale. CSC has approximately 74,000 employees and reported revenue of $12.9 billion for the 12 months ended October 3, 2014. For more information, visit the company's website at www.csc.com.